What is Status 4?
Status 4 is a comprehensive medical reference and training application designed for emergency medical personnel. It provides offline access to a vast amount of information, including medications, algorithms, scores, and calculators, to assist users in their daily work and professional development.
Does Status 4 have ads?
No, Status 4 is ad-free. The app is designed to provide an uninterrupted and focused experience for medical professionals, ensuring no advertisements interfere with critical information access.
What medical information is available in Status 4?
Status 4 includes information on 298 medications from 11 different regional sources, emergency algorithms for conditions like reanimation and stroke, various medical scores (GCS, APGAR, qSOFA, NEWS2), and specialized calculators for pediatrics and burns. It also features a sonography trainer with real images.
Can I use Status 4 offline?
Yes, Status 4 is 100% offline. This means you can access all its features and information even in areas with no internet connection, such as during emergencies or in remote locations.
What devices does Status 4 support?
Status 4 is available on Apple Watch, iPhone, iPad, and iPod. This allows for flexible access to medical information and tools across various Apple devices.
How often is Status 4 updated?
The latest version of Status 4 is 1.9.4, and it was last updated on August 17, 2026. This indicates a commitment to keeping the app current with the latest medical guidelines and features.
What is the age rating for Status 4?
Status 4 has an age rating of 12+. This suggests that the content is generally suitable for users aged 12 and above, though its primary audience is medical professionals.
Does Status 4 offer multilingual support?
Yes, Status 4 provides over 25 anamnesis questions in 10 different languages, including English, Turkish, Arabic, Russian, Ukrainian, French, Polish, Farsi, Romanian, and Italian. It also features a read-aloud function and offline translation capabilities for custom sentences.
